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Background:  Left ventricular non-compaction (LVNC) is a rare congenital morphogenetic disorder, and its prevalence and clinical significance 
has not been clearly determined. Historically, LVNC has been associated with worse cardiac outcomes, but recent studies have showed a relatively 
mild clinical course. However, there are no large scale studies looking at the association of LVNC with cardiovascular outcomes (CVO). We sought 
to assess both the prevalence and prognostic significance of LVNC diagnosed by current cardiac magnetic resonance (CMR) diagnostic criteria 
compared to those with normal compacted myocardium (control).
Methods:  We evaluated the images of 769 consecutive patients who underwent CMR for cardiac evaluation. We assessed the non-compacted 
and compacted myocardium by drawing the diameters of each in the apical, mid and basal segments in 2 long-axis cine views. LVNC was defined as 
non-compacted to compacted ratio (NC/C) of ≥2.3 in any of the three analyses. Patients were followed by telephone and by hospital chart review to 
confirm the following outcomes: all-cause mortality, exacerbation of CHF, defined as a decrease in NYHA functional class, or re-hospitalization due to 
a cardiac etiology.
Results:  The mean age of our study population was 59 years and 57% were males. The patients were referred to CMR for: evaluation of left 
ventricular function (42%), viability (24%), valvular disease (24%), and other (10%). The mean follow up was 2.8 ± 1.8 years. Of the 769 patients, 
157 patients (20%) had NC/C of ≥2.3 in at least one segment. The prevalence of NC/C of ≥2.3 in the apical, mid and basal segments was 20%, 
3.4% and 0.5%, respectively. Patients with LVNC tend to be older and have a lower incidence of hypertension. The mean LVEF and incidence of stroke 
were not significantly different between the groups. Patients with LVNC had less cardiac related hospitalizations. All-cause mortality, worsening CHF 
and a composite of all CVO in the LVNC group were not significantly different to the normal group. 
Conclusions:  Using the current recommended criteria, the prevalence of LVNC in patients referred for a CMR is 100 times higher than previously 
reported. LVNC was not associated with an increase in CVO.
